China Cancer Gene Therapy Market Report & Forecast 2021-2027

China Cancer Gene Therapy Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Cancer Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Cancer Gene Therapy Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Cancer Gene Therapy Overall Market Size
2.1 China Cancer Gene Therapy Market Size: 2021 VS 2027
2.2 China Cancer Gene Therapy Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Gene Therapy Players in China Market
3.2 Top China Cancer Gene Therapy Companies Ranked by Revenue
3.3 China Cancer Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Gene Therapy Companies in China Market, by Revenue in 2020
3.5 Companies Cancer Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Gene Therapy Players in China Market
3.6.1 List of Tier 1 Cancer Gene Therapy Companies in China
3.6.2 List of Tier 2 and Tier 3 Cancer Gene Therapy Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Cancer Gene Therapy Market Size Markets, 2021 & 2027
4.1.2 Oncolytic Virotherapy
4.1.3 Gene Transfer
4.1.4 Gene-Induced Immunotherapy
4.2 By Type - China Cancer Gene Therapy Revenue & Forecasts
4.2.1 By Type - China Cancer Gene Therapy Revenue, 2016-2021
4.2.2 By Type - China Cancer Gene Therapy Revenue, 2022-2027
4.2.3 By Type - China Cancer Gene Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Cancer Gene Therapy Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Diagnostics Centers
5.1.4 Research Institutes
5.2 By Application - China Cancer Gene Therapy Revenue & Forecasts
5.2.1 By Application - China Cancer Gene Therapy Revenue, 2016-2021
5.2.2 By Application - China Cancer Gene Therapy Revenue, 2022-2027
5.2.3 By Application - China Cancer Gene Therapy Revenue Market Share, 2016-2027
6 Cancer Gene Therapy Companies Profiles
6.1 Adaptimmune
6.1.1 Adaptimmune Company Details
6.1.2 Adaptimmune Business Overview
6.1.3 Adaptimmune Cancer Gene Therapy Introduction
6.1.4 Adaptimmune Cancer Gene Therapy Revenue in China Market (2016-2021)
6.1.5 Adaptimmune Recent Developments
6.2 Bluebird bio
6.2.1 Bluebird bio Company Details
6.2.2 Bluebird bio Business Overview
6.2.3 Bluebird bio Cancer Gene Therapy Introduction
6.2.4 Bluebird bio Cancer Gene Therapy Revenue in China Market (2016-2021)
6.2.5 Bluebird bio Recent Developments
6.3 Celgene
6.3.1 Celgene Company Details
6.3.2 Celgene Business Overview
6.3.3 Celgene Cancer Gene Therapy Introduction
6.3.4 Celgene Cancer Gene Therapy Revenue in China Market (2016-2021)
6.3.5 Celgene Recent Developments
6.4 Shanghai Sunway Biotech
6.4.1 Shanghai Sunway Biotech Company Details
6.4.2 Shanghai Sunway Biotech Business Overview
6.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Introduction
6.4.4 Shanghai Sunway Biotech Cancer Gene Therapy Revenue in China Market (2016-2021)
6.4.5 Shanghai Sunway Biotech Recent Developments
6.5 Shenzhen SiBiono GeneTech
6.5.1 Shenzhen SiBiono GeneTech Company Details
6.5.2 Shenzhen SiBiono GeneTech Business Overview
6.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Introduction
6.5.4 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue in China Market (2016-2021)
6.5.5 Shenzhen SiBiono GeneTech Recent Developments
6.6 SynerGene Therapeutics
6.6.1 SynerGene Therapeutics Company Details
6.6.2 SynerGene Therapeutics Business Overview
6.6.3 SynerGene Therapeutics Cancer Gene Therapy Introduction
6.6.4 SynerGene Therapeutics Cancer Gene Therapy Revenue in China Market (2016-2021)
6.6.5 SynerGene Therapeutics Recent Developments
6.7 Altor BioScience
6.7.1 Altor BioScience Company Details
6.7.2 Altor BioScience Business Overview
6.7.3 Altor BioScience Cancer Gene Therapy Introduction
6.7.4 Altor BioScience Cancer Gene Therapy Revenue in China Market (2016-2021)
6.7.5 Altor BioScience Recent Developments
6.8 Amgen
6.8.1 Amgen Company Details
6.8.2 Amgen Business Overview
6.8.3 Amgen Cancer Gene Therapy Introduction
6.8.4 Amgen Cancer Gene Therapy Revenue in China Market (2016-2021)
6.8.5 Amgen Recent Developments
6.9 Argenx
6.9.1 Argenx Company Details
6.9.2 Argenx Business Overview
6.9.3 Argenx Cancer Gene Therapy Introduction
6.9.4 Argenx Cancer Gene Therapy Revenue in China Market (2016-2021)
6.9.5 Argenx Recent Developments
6.10 BioCancell
6.10.1 BioCancell Company Details
6.10.2 BioCancell Business Overview
6.10.3 BioCancell Cancer Gene Therapy Introduction
6.10.4 BioCancell Cancer Gene Therapy Revenue in China Market (2016-2021)
6.10.5 BioCancell Recent Developments
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Company Details
6.11.2 GlaxoSmithKline Business Overview
6.11.3 GlaxoSmithKline Cancer Gene Therapy Introduction
6.11.4 GlaxoSmithKline Cancer Gene Therapy Revenue in China Market (2016-2021)
6.11.5 GlaxoSmithKline Recent Developments
6.12 Merck
6.12.1 Merck Company Details
6.12.2 Merck Business Overview
6.12.3 Merck Cancer Gene Therapy Introduction
6.12.4 Merck Cancer Gene Therapy Revenue in China Market (2016-2021)
6.12.5 Merck Recent Developments
6.13 OncoGenex Pharmaceuticals
6.13.1 OncoGenex Pharmaceuticals Company Details
6.13.2 OncoGenex Pharmaceuticals Business Overview
6.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Introduction
6.13.4 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue in China Market (2016-2021)
6.13.5 OncoGenex Pharmaceuticals Recent Developments
6.14 Transgene
6.14.1 Transgene Company Details
6.14.2 Transgene Business Overview
6.14.3 Transgene Cancer Gene Therapy Introduction
6.14.4 Transgene Cancer Gene Therapy Revenue in China Market (2016-2021)
6.14.5 Transgene Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Cancer Gene Therapy Market Opportunities & Trends in China Market
Table 2. Cancer Gene Therapy Market Drivers in China Market
Table 3. Cancer Gene Therapy Market Restraints in China Market
Table 4. Key Players of Cancer Gene Therapy in China Market
Table 5. Top Cancer Gene Therapy Players in China Market, Ranking by Revenue (2019)
Table 6. China Cancer Gene Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Cancer Gene Therapy Revenue Share by Companies, 2016-2021
Table 8. Companies Cancer Gene Therapy Product Type
Table 9. List of Tier 1 Cancer Gene Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Cancer Gene Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Cancer Gene Therapy Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Cancer Gene Therapy Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Cancer Gene Therapy Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Cancer Gene Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Cancer Gene Therapy Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Cancer Gene Therapy Revenue (US$, Mn), 2022-2027
Table 17. Adaptimmune Company Details
Table 18. Adaptimmune Business Overview
Table 19. Adaptimmune Cancer Gene Therapy Product
Table 20. Adaptimmune Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Adaptimmune Recent Developments
Table 22. Bluebird bio Company Details
Table 23. Bluebird bio Business Overview
Table 24. Bluebird bio Cancer Gene Therapy Product
Table 25. Bluebird bio Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Bluebird bio Recent Developments
Table 27. Celgene Company Details
Table 28. Celgene Business Overview
Table 29. Celgene Cancer Gene Therapy Product
Table 30. Celgene Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Celgene Recent Developments
Table 32. Shanghai Sunway Biotech Company Details
Table 33. Shanghai Sunway Biotech Business Overview
Table 34. Shanghai Sunway Biotech Cancer Gene Therapy Product
Table 35. Shanghai Sunway Biotech Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Shanghai Sunway Biotech Recent Developments
Table 37. Shenzhen SiBiono GeneTech Company Details
Table 38. Shenzhen SiBiono GeneTech Business Overview
Table 39. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product
Table 40. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Shenzhen SiBiono GeneTech Recent Developments
Table 42. SynerGene Therapeutics Company Details
Table 43. SynerGene Therapeutics Business Overview
Table 44. SynerGene Therapeutics Cancer Gene Therapy Product
Table 45. SynerGene Therapeutics Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 46. SynerGene Therapeutics Recent Developments
Table 47. Altor BioScience Company Details
Table 48. Altor BioScience Business Overview
Table 49. Altor BioScience Cancer Gene Therapy Product
Table 50. Altor BioScience Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Altor BioScience Recent Developments
Table 52. Amgen Company Details
Table 53. Amgen Business Overview
Table 54. Amgen Cancer Gene Therapy Product
Table 55. Amgen Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Amgen Recent Developments
Table 57. Argenx Company Details
Table 58. Argenx Business Overview
Table 59. Argenx Cancer Gene Therapy Product
Table 60. Argenx Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Argenx Recent Developments
Table 62. BioCancell Company Details
Table 63. BioCancell Business Overview
Table 64. BioCancell Cancer Gene Therapy Product
Table 65. BioCancell Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 66. BioCancell Recent Developments
Table 67. GlaxoSmithKline Company Details
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Cancer Gene Therapy Product
Table 70. GlaxoSmithKline Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 71. GlaxoSmithKline Recent Developments
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Cancer Gene Therapy Product
Table 75. Merck Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 76. Merck Recent Developments
Table 77. OncoGenex Pharmaceuticals Company Details
Table 78. OncoGenex Pharmaceuticals Business Overview
Table 79. OncoGenex Pharmaceuticals Cancer Gene Therapy Product
Table 80. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 81. OncoGenex Pharmaceuticals Recent Developments
Table 82. Transgene Company Details
Table 83. Transgene Business Overview
Table 84. Transgene Cancer Gene Therapy Product
Table 85. Transgene Cancer Gene Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 86. Transgene Recent Developments
List of Figures
Figure 1. Cancer Gene Therapy Segment by Type
Figure 2. Cancer Gene Therapy Segment by Application
Figure 3. China Cancer Gene Therapy Market Overview: 2020
Figure 4. China Cancer Gene Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Cancer Gene Therapy Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2020
Figure 7. By Type - China Cancer Gene Therapy Revenue Market Share, 2016-2027
Figure 8. By Application - China Cancer Gene Therapy Revenue Market Share, 2016-2027
Figure 9. Adaptimmune Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Bluebird bio Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Celgene Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Shanghai Sunway Biotech Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. SynerGene Therapeutics Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Altor BioScience Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Amgen Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Argenx Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. BioCancell Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. GlaxoSmithKline Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Merck Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Transgene Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs